Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Technical Reports on Hospitals Equities -- Community Health Systems, HCA Healthcare, Tenet Healthcare, and Nobilis Health

Chelmsford Park SA
Posted on: 19 Aug 17

NEW YORK, August 18, 2017 /PRNewswire/ --

If you want a Stock Review on CYH, HCA, THC, or HLTH then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. Industries in the Hospitals subsector provide medical, diagnostic, and treatment services that include physician, nursing, and other health services to inpatients and the specialized accommodation services required by inpatients. Hospitals may also provide outpatient services as a secondary activity. Pre-market today, DailyStockTracker.com takes a closer look at the following equities: Community Health Systems Inc. (NYSE: CYH), HCA Healthcare Inc. (NYSE: HCA), Tenet Healthcare Corp. (NYSE: THC), and Nobilis Health Corp. (NYSEMKT: HLTH). Learn more about these stocks by downloading their comprehensive and free reports from DailyStockTracker.com member's area at:

http://dailystocktracker.com/register/

Community Health Systems 

On Thursday, shares in Franklin, Tennessee headquartered Community Health Systems Inc. saw a decline of 1.44%, ending the day at $6.84. The stock recorded a trading volume of 2.71 million shares. The Company's shares have advanced 22.36% since the start of this year. The stock is trading below its 200-day moving average by 12.18%. Moreover, shares of Community Health Systems, which together with its subsidiaries, owns, leases, and operates general acute care hospitals in the US, have a Relative Strength Index (RSI) of 40.75.

On August 01st, 2017, Community Health Systems announced financial and operating results for the three months ended June 30th, 2017. For Q2 2017, net operating revenues totaled $4.14 billion; net loss was $(137) million; and adjusted EBITDA was $435 million. Cash flow from operations was $261 million for the quarter compared to $338 million for the same period in 2016; representing a 22.8% decrease. CYH complete research report is just a click away at:

http://dailystocktracker.com/registration/?symbol=CYH

HCA Healthcare 

Shares in Nashville, Tennessee headquartered HCA Healthcare Inc. ended the day 1.52% lower at $77.79. A total volume of 1.45 million shares was traded. The stock has gained 5.09% on an YTD basis, and is trading below its 200-day moving average by 4.51%. Furthermore, shares of HCA Healthcare, which through its subsidiaries, provides health care services in the US and England, have an RSI of 31.29.  

On July 21st, 2017, HCA Healthcare announced an agreement to acquire Highlands Regional Medical Center in Sebring, Florida from subsidiaries of Community Health Systems, Inc. Upon completion of the transaction, Highlands Regional Medical Center, a 126-bed hospital 75 miles west of Fort Pierce, will be part of the Company's East Florida Division.

On July 26th, 2017, research firm Bank of America/ Merrill downgraded the Company's stock rating from 'Buy' to 'Neutral'. The complimentary report on HCA can be downloaded at:

http://dailystocktracker.com/registration/?symbol=HCA

Tenet Healthcare 

At the close of trading on Thursday, shares in Dallas, Texas headquartered Tenet Healthcare Corp. finished 2.09% lower at $12.65 with a total trading volume of 3.20 million shares. The stock is trading below its 200-day moving average by 27.66%. Shares of the Company, which together with its subsidiaries, operates as a diversified healthcare services company, have an RSI of 23.33.  

On August 01st, 2017, Tenet Healthcare announced that the Company has completed the sale of its Houston-area acute care hospitals and related operations to HCA Healthcare, Inc. for net pre-tax proceeds of approximately $750 million in cash, effective that day. The facilities included in the sale are three acute care hospitals (Cypress Fairbanks Medical Center, Houston Northwest Medical Center, and Park Plaza Hospital) and one, long-term acute care hospital (Plaza Specialty Hospital) as well as other hospital-affiliated entities, including physician practices.

On August 08th, 2017, research firm Jefferies reiterated its 'Buy' rating on the Company's stock with a decrease of the target price from $26 a share to $24 a share. Sign up for your complimentary research report on THC at:

http://dailystocktracker.com/registration/?symbol=THC

Nobilis Health 

Houston, Texas headquartered Nobilis Health Corp.'s shares recorded a trading volume of 389,867 shares at the end of yesterday's session. The stock closed the day 3.03% higher at $1.70. The Company's shares have advanced 25.93% in the previous three months. The stock is trading below its 50-day moving average by 1.31%. Additionally, shares of Nobilis Health, which together with its subsidiaries, acquires and manages ambulatory surgical centers and healthcare facilities in the US, have an RSI of 56.02.

On August 02nd, 2017, Nobilis Health announced financial results for Q2 ended June 30th, 2017. For Q2 2017, revenue was $80.0 million; net income was $1.6 million; and adjusted EBITDA was $10.1 million. Total cash was $29.2 million, accounts receivable was $110.4 million, and total bank debt was $66.9 million as of June 30th, 2017. Get free access to your research report on HLTH at:

http://dailystocktracker.com/registration/?symbol=HLTH

--

Daily Stock Tracker: 

Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

DST has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@dailystocktracker.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  

NO WARRANTY 

DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING 

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

http://dailystocktracker.com/disclaimer/

CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: contact@dailystocktracker.com
Phone number: (207)331-3313
Office Address: 377 Rivonia Boulevard, Rivonia, South Africa

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 19/08/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.